DE

447.26

-4.91%↓

FDX

215.59

-12.15%↓

PAYX

153.66

-0.92%↓

CPRT

56.65

-1.58%↓

HEICA

203.75

-4.28%↓

DE

447.26

-4.91%↓

FDX

215.59

-12.15%↓

PAYX

153.66

-0.92%↓

CPRT

56.65

-1.58%↓

HEICA

203.75

-4.28%↓

DE

447.26

-4.91%↓

FDX

215.59

-12.15%↓

PAYX

153.66

-0.92%↓

CPRT

56.65

-1.58%↓

HEICA

203.75

-4.28%↓

DE

447.26

-4.91%↓

FDX

215.59

-12.15%↓

PAYX

153.66

-0.92%↓

CPRT

56.65

-1.58%↓

HEICA

203.75

-4.28%↓

DE

447.26

-4.91%↓

FDX

215.59

-12.15%↓

PAYX

153.66

-0.92%↓

CPRT

56.65

-1.58%↓

HEICA

203.75

-4.28%↓

Search

Enovis Corp

Geschlossen

BrancheIndustrie

33.75 -8.73

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

33.59

Max

35.14

Schlüsselkennzahlen

By Trading Economics

Einkommen

-672M

-703M

Verkäufe

56M

561M

EPS

0.98

Gewinnspanne

-125.353

Angestellte

7,367

EBITDA

-602M

-590M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+69.58% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

1. Mai 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-445M

2.2B

Vorheriger Eröffnungskurs

42.48

Vorheriger Schlusskurs

33.75

Nachrichtenstimmung

By Acuity

25%

75%

70 / 468 Ranking in Industrials

Enovis Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Jan. 2025, 23:28 UTC

Wichtige Markttreiber

Maplebear Up on S&P MidCap 400 Inclusion

Peer-Vergleich

Kursveränderung

Enovis Corp Prognose

Kursziel

By TipRanks

69.58% Vorteil

12-Monats-Prognose

Durchschnitt 62.71 USD  69.58%

Hoch 75 USD

Tief 46 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Enovis Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

8 ratings

7

Buy

1

Halten

0

Sell

Stimmung

By Acuity

70 / 468 Ranking in Industrie

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Durchschnitt

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Enovis Corp

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.